Cargando…

One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons from the COMBAT Multicentre Prospective Study

INTRODUCTION: COMBAT is a prospective, multicentre cohort study that enrolled consecutive adults with community-acquired bacterial meningitis (CABM) in 69 participating centres in France between February 2013 and July 2015 and followed them for 1 year. METHODS: Patients aged at least 18 years old, h...

Descripción completa

Detalles Bibliográficos
Autores principales: Duval, Xavier, Taha, Muhamed-Kheir, Lamaury, Isabelle, Escaut, Lélia, Gueit, Isabelle, Manchon, Pauline, Tubiana, Sarah, Hoen, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123035/
https://www.ncbi.nlm.nih.gov/pubmed/35484469
http://dx.doi.org/10.1007/s12325-022-02149-7
_version_ 1784711476345307136
author Duval, Xavier
Taha, Muhamed-Kheir
Lamaury, Isabelle
Escaut, Lélia
Gueit, Isabelle
Manchon, Pauline
Tubiana, Sarah
Hoen, Bruno
author_facet Duval, Xavier
Taha, Muhamed-Kheir
Lamaury, Isabelle
Escaut, Lélia
Gueit, Isabelle
Manchon, Pauline
Tubiana, Sarah
Hoen, Bruno
author_sort Duval, Xavier
collection PubMed
description INTRODUCTION: COMBAT is a prospective, multicentre cohort study that enrolled consecutive adults with community-acquired bacterial meningitis (CABM) in 69 participating centres in France between February 2013 and July 2015 and followed them for 1 year. METHODS: Patients aged at least 18 years old, hospitalised with CABM were followed during their hospitalisation and then contacted by phone 12 months after enrolment. Here we present the prevalence of sequelae at 12 months in a subgroup of patients with meningococcal meningitis. RESULTS: Five of the 111 patients with meningococcal meningitis died during initial hospitalisation and two died between discharge and 12 months, leaving 104 patients alive 1 year after enrolment, 71 of whom provided 12-month follow-up data. The median age was 30.0 years and 54.1% of the patients had no identified risk factor for meningitis. More than 30% reported persistent headache, more than 40% were not satisfied with their sleep and 10% had concentration difficulties. Hearing loss was present in about 15% of the patients and more than 30% had depressive symptoms. About 13% of the patients with a previous professional activity had not resumed work. On the SF-12 Health Survey, almost 50% and 30% had physical component or mental component scores lower than the 25th percentile of the score distribution in the French general population. There was a non-significant improvement in the patients’ disability scores from hospital discharge to 12 months (p = 0.16), but about 10% of the patients had residual disability. CONCLUSIONS: Although most patients in our cohort survive meningococcal meningitis, the long-term burden is substantial and therefore it is important to ensure a prolonged follow-up of survivors and to promote preventive strategies, including vaccination. TRIAL REGISTRATION: ClinicalTrial.Gov identification number NCT01730690. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-022-02149-7.
format Online
Article
Text
id pubmed-9123035
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-91230352022-05-22 One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons from the COMBAT Multicentre Prospective Study Duval, Xavier Taha, Muhamed-Kheir Lamaury, Isabelle Escaut, Lélia Gueit, Isabelle Manchon, Pauline Tubiana, Sarah Hoen, Bruno Adv Ther Brief Report INTRODUCTION: COMBAT is a prospective, multicentre cohort study that enrolled consecutive adults with community-acquired bacterial meningitis (CABM) in 69 participating centres in France between February 2013 and July 2015 and followed them for 1 year. METHODS: Patients aged at least 18 years old, hospitalised with CABM were followed during their hospitalisation and then contacted by phone 12 months after enrolment. Here we present the prevalence of sequelae at 12 months in a subgroup of patients with meningococcal meningitis. RESULTS: Five of the 111 patients with meningococcal meningitis died during initial hospitalisation and two died between discharge and 12 months, leaving 104 patients alive 1 year after enrolment, 71 of whom provided 12-month follow-up data. The median age was 30.0 years and 54.1% of the patients had no identified risk factor for meningitis. More than 30% reported persistent headache, more than 40% were not satisfied with their sleep and 10% had concentration difficulties. Hearing loss was present in about 15% of the patients and more than 30% had depressive symptoms. About 13% of the patients with a previous professional activity had not resumed work. On the SF-12 Health Survey, almost 50% and 30% had physical component or mental component scores lower than the 25th percentile of the score distribution in the French general population. There was a non-significant improvement in the patients’ disability scores from hospital discharge to 12 months (p = 0.16), but about 10% of the patients had residual disability. CONCLUSIONS: Although most patients in our cohort survive meningococcal meningitis, the long-term burden is substantial and therefore it is important to ensure a prolonged follow-up of survivors and to promote preventive strategies, including vaccination. TRIAL REGISTRATION: ClinicalTrial.Gov identification number NCT01730690. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-022-02149-7. Springer Healthcare 2022-04-28 2022 /pmc/articles/PMC9123035/ /pubmed/35484469 http://dx.doi.org/10.1007/s12325-022-02149-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Brief Report
Duval, Xavier
Taha, Muhamed-Kheir
Lamaury, Isabelle
Escaut, Lélia
Gueit, Isabelle
Manchon, Pauline
Tubiana, Sarah
Hoen, Bruno
One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons from the COMBAT Multicentre Prospective Study
title One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons from the COMBAT Multicentre Prospective Study
title_full One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons from the COMBAT Multicentre Prospective Study
title_fullStr One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons from the COMBAT Multicentre Prospective Study
title_full_unstemmed One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons from the COMBAT Multicentre Prospective Study
title_short One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons from the COMBAT Multicentre Prospective Study
title_sort one-year sequelae and quality of life in adults with meningococcal meningitis: lessons from the combat multicentre prospective study
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123035/
https://www.ncbi.nlm.nih.gov/pubmed/35484469
http://dx.doi.org/10.1007/s12325-022-02149-7
work_keys_str_mv AT duvalxavier oneyearsequelaeandqualityoflifeinadultswithmeningococcalmeningitislessonsfromthecombatmulticentreprospectivestudy
AT tahamuhamedkheir oneyearsequelaeandqualityoflifeinadultswithmeningococcalmeningitislessonsfromthecombatmulticentreprospectivestudy
AT lamauryisabelle oneyearsequelaeandqualityoflifeinadultswithmeningococcalmeningitislessonsfromthecombatmulticentreprospectivestudy
AT escautlelia oneyearsequelaeandqualityoflifeinadultswithmeningococcalmeningitislessonsfromthecombatmulticentreprospectivestudy
AT gueitisabelle oneyearsequelaeandqualityoflifeinadultswithmeningococcalmeningitislessonsfromthecombatmulticentreprospectivestudy
AT manchonpauline oneyearsequelaeandqualityoflifeinadultswithmeningococcalmeningitislessonsfromthecombatmulticentreprospectivestudy
AT tubianasarah oneyearsequelaeandqualityoflifeinadultswithmeningococcalmeningitislessonsfromthecombatmulticentreprospectivestudy
AT hoenbruno oneyearsequelaeandqualityoflifeinadultswithmeningococcalmeningitislessonsfromthecombatmulticentreprospectivestudy
AT oneyearsequelaeandqualityoflifeinadultswithmeningococcalmeningitislessonsfromthecombatmulticentreprospectivestudy